Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

By altering the metabolism of the skin, the Zika virus guarantees its own survival, resulting in turning humans into mosquito ...

Pune reported nine suspected new cases of Guillain-Barre Syndrome (GBS), raising the city's total to 110 cases. Health officials have noted gender distribution, ventilator usage, and are conducting ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...

Recent outbreak of Guillain–Barré syndrome in Pune causing panic, symptoms, diagnosis, treatment, and prevention explained in ...

The virus-like particle (VLP) single-dose chikungunya vaccine is expected ... that the vaccine can induce protection from CHIKV infection by inducing neutralising antibodies against certain ...